Genomic Health (GHDX)
Genomic Health Beneish M-Score: -2.480
View GHDX Beneish M-Score with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
GHDX Beneish M-Score Rankings
| Overall | 39th percentile | 2292 of 3761 |
| Sector | 46th percentile | 184 of 342 in Healthcare |
| Industry | 33rd percentile | 14 of 21 in Medical Laboratories & Research |
GHDX Beneish M-Score Range, Past 5 Years
| Minimum | -2.985 | Dec 2009 |
| Maximum | -1.674 | Dec 2007 |
| Average | -2.460 |
About Beneish M Score
The Beneish M Score helps to uncover companies who are likely to be manipulating their reported earnings. Companies with a higher score are more likely to be manipulators. This is a probabilistic model, so it will not detect manipulators with 100% accuracy.
The best cut-off point depends on the costs mistakenly classifying in one of two ways:
1) Classifying firm that is manipulating earnings as a non-manipulator (Type I error), and
2) Classifying a firm as a manipulator when it actually was not manipulating (Type II Error).
Here are optimal cut-offs according to Beneish, presented as the score followed by the cost of Type I error relative to cost of Type II error):
M Score HTML Table:
| Score | Relative Error Costs (Type I:Type II) |
|---|---|
| M Score > -1.49 | (10:1) | M Score > -1.78 | (20:1) | M Score > -1.89 | (40+:1) |
Beneish excluded financial institutions from his sample when calculating the M-Score, so extreme care should be taken when looking at M-Scores of financial firms - their business models are different from the manufacturing and other service firms that Beneish used in his study.
If you want more details, here is the original Beneish M Score Paper, or you can learn about our calculation by clicking "Learn More" below.
Learn More
You may also be interested in these GHDX related companies
GHDX News
NEW POST: "A Bit Too Rare" http://stks.co/3ySS $GENE $GHDX $MYGN $QQQ $ROSG $SPY
about 5 days ago by chessNwine
about 5 days ago by chessNwine
$GHDX Insider Buy: $5.4M of stock bought by Felix Baker between May 21, 2012 - May 22, 2012 http://stks.co/3xjR
about 6 days ago by MarketBrief
about 6 days ago by MarketBrief
$GHDX Insider Buy: $12.7M of stock bought by Felix Baker between May 14, 2012 - May 16, 2012 http://stks.co/3rdD
about 13 days ago by MarketBrief
about 13 days ago by MarketBrief
10 breakouts: $BONA, $GHDX. Two sub-$1 and no penny stocks. Slow day but no focus on weak stocks, just a lack of interest
about 15 days ago by fallondpicks
about 15 days ago by fallondpicks
Genomic Health, Marriott Vacations Worldwide Among Stocks Setting 52-Week Highs Monday
May 14, 4:32PM Fox Business
May 14, 4:32PM Fox Business
$GHDX Another Baker Brothers favorite, crushing it over the last 6 trading days. This kind of move & volume in this crappy market? Whats up?
about 15 days ago by PTSD_Trader
about 15 days ago by PTSD_Trader
Ruparelia's picks in diagnostic testing, robots and 3D printing: $GHDX $IRBT $SSYS $DDD http://stks.co/3nhk
about 16 days ago by covestor
about 16 days ago by covestor
$GHDX I like the volume/accumulation here. Keeping on watch list. New name for me. http://chart.ly/bl5p3dd
about 17 days ago by BrettPerlman
about 17 days ago by BrettPerlman
$GHDX Insider Buy: $3.4M of stock bought by Felix Baker between May 9, 2012 - May 11, 2012 http://stks.co/3nPM
about 18 days ago by MarketBrief
about 18 days ago by MarketBrief
$GHDX Insider Buy: $5.6M of stock bought by Felix Baker between May 4, 2012 - May 8, 2012 http://stks.co/3jWm
about 21 days ago by MarketBrief
about 21 days ago by MarketBrief
Canaccord Genuity Maintains a 'Hold' on Genomic Health (GHDX); Raising PT and Estimates
May 03, 9:44AM Street Insider
May 03, 9:44AM Street Insider
Genomic Health Announces First Quarter 2012 Financial Results and Business Progress
May 02, 4:01PM PR Newswire
May 02, 4:01PM PR Newswire
Genomic Health (GHDX) to Report New Data from Recent Oncotype DX Clinicals
Mar 21, 7:03AM Street Insider
Mar 21, 7:03AM Street Insider
$GHDX http://stks.co/2p6Y Continues to act well on nice price & volume profile. Back near HOD.
about 77 days ago by Fibline
about 77 days ago by Fibline
Baker Bros stake in $GHDX is now over 35% of the whole company. There's really only one way to sell out of a position like that one day.
about 79 days ago by bradloncar
about 79 days ago by bradloncar
RT @ElliotTurn: Best idea from Barron's= $GHDX, w/ Baker Bros. accumulating a massive stake in the provider of personalized genomics-based
about 80 days ago by WallStJesus
about 80 days ago by WallStJesus
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| GHDX | 34.67 | +0.11 | +0.32% | 1.036B |
| GGT | 6.72 | +0.08 | +1.20% | |
| GGR | 0.1999 | -0.00 | -0.05% | 19.83M |
| GGP | 17.07 | +0.26 | +1.55% | |
| FRT | 99.42 | +0.83 | +0.84% | 6.277B |
| FRS | 27.18 | -0.04 | -0.15% | 134.47M |
| FRP | 5.39 | -0.13 | -2.36% | |
| FRO | 5.31 | -0.07 | -1.30% | 418.89M |
| FORTY | 16.00 | -0.22 | -1.36% | 226.24M |
| FORR | 33.27 | -0.04 | -0.12% | 755.14M |
